WILL RUTLAND: Open Payments
NPI 1194256271 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 30 payments from 11 companies in 2025. Trend: 2023 $540 · 2024 $450 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $170 |
| Indivior Inc. | 3 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Corium, LLC | 3 | $43 |
| Tris Pharma Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: INGREZZA, SUBLOCADE, TRINTELLIX, Auvelity, COBENFY, Azstarys, Dyanavel XR, FANAPT.
Industry payments across CT — which companies pay providers there.
